Glucose News and Research

RSS

VeriChip collaborates with DRI for further development of the glucose-sensing RFID microchip

VeriChip Corporation announced today that it has entered into a strategic partnership with the Diabetes Research Institute ("DRI") to combine efforts on the further development of the glucose-sensing radio frequency identification (RFID) microchip in conjunction with VeriChip's development partner, RECEPTORS LLC.

22 Oct 2009

Edwards Lifesciences announces third quarter 2009 results

Edwards Lifesciences Corporation, a world leader in products and technologies to treat advanced cardiovascular disease, today reported net income for the quarter ended September 30, 2009 of $73.5 million, or $1.25 per diluted share, compared to net income of $32.9 million, or $0.56 per diluted share, for the same period in 2008.

22 Oct 2009

New findings from ADVANCE clinical trial presented

New analyses of the largest-ever clinical trial of patients with type 2 diabetes show that the combination of blood pressure lowering treatment and intensive glucose (blood sugar) control improved patients' vascular condition and resulted in a significant 18 percent reduction in the risk of death from all causes.

22 Oct 2009

InHealth awards Southern California, Northwestern and Stanford Universities $1.4M as research grants

The Institute for Health Technology Studies (InHealth) has awarded three new research grants totaling more than $1.4 million to investigators at the University of Southern California, Northwestern University, and Stanford University. The funding will support three separate studies that will examine the social and economic impact of therapeutic medical devices, as well as the device innovation process.

22 Oct 2009

Positive results from Isis Pharmaceuticals' ISIS 113715 Phase 2 study in type 2 diabetes patients

Isis Pharmaceuticals, Inc. today announced positive top-line results from a Phase 2 study evaluating the safety and efficacy of ISIS 113715 in patients with type 2 diabetes. ISIS 113715 is a novel insulin sensitizer that reduces the expression of protein tyrosine phosphatase-1B (PTP-1B). The study showed consistent and statistically significant reductions in multiple short and intermediate measures of glucose control.

22 Oct 2009

New results from ADVANCE provide important insights to reduce diabetes complications

New results from ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation), the largest clinical trial ever performed in patients with type 2 diabetes worldwide, provide important insights into the therapeutic strategy to adopt for efficient and safe blood glucose control aimed at the reduction of severe diabetes complications.

21 Oct 2009

Rexall Diabetes Starter Kit for newly diagnosed patients

Over 40 per cent of Canadians diagnosed with a life-threatening disease, such as diabetes, feel confused or overwhelmed after leaving their doctor's office, shows a Leger Marketing survey commissioned by the Rexall family of pharmacies.

20 Oct 2009

Diabetes represents a global health threat

The International Diabetes Federation (IDF) released new data today showing that a staggering 285 million people worldwide have diabetes.

20 Oct 2009

Children with history of diabetic ketoacidosis may have memory problems

Children who have had an episode of diabetic ketoacidosis, a common complication of diabetes, may have persistent memory problems, according to a new study from researchers at the UC Davis Center for Mind and Brain.

19 Oct 2009

Hygeia questions the recently issued state bid notification for breastpumps

In the USA, each state is responsible for its Women Infant Children program and encourages breastfeeding through lactation counseling and the purchase of supplies. A state bid notification for breastpumps and supplies was recently issued. "This bid had such an unusual feature that needs further attention. The bid's breastpump requirement was that the pumps only had to work for 90% of the women. The state felt that it was acceptable for the pumps to fail for 10% of the women," stated John Estill, CEO of breastpump manufacturer Hygeia.

19 Oct 2009

MDEA program is accepting entries for its 2010 competition

The Medical Design Excellence Awards (MDEA) program is accepting entries for its 2010 competition from companies and individuals worldwide involved in the design, engineering, manufacture, or distribution of finished medical devices or packaging products.

15 Oct 2009

Study shows type 2 diabetes patients treated with ACTOplus met experience blood sugar reduction

A study, published online in the journal Current Medical Research and Opinion, showed that a greater percentage of patients with type 2 diabetes treated with the fixed-dose combination ACTOplus met® (pioglitazone HCl and metformin HCl) as initial therapy reached the study goal of hemoglobin A1c (HbA1c) of less than or equal to 7 percent compared to either component alone.

15 Oct 2009

ValenTx to present its first clinical study for the treatment of morbid obesity

ValenTx, Inc. announces the presentation of the first clinical study of their endoluminal approach for the treatment of morbid obesity at the 2009 American College of Surgeons Clinical Congress.

15 Oct 2009

New non-invasive technology to measure glucose levels in the human eye

New non-invasive technology designed to painlessly measure glucose levels in the human eye shows promise of one day replacing the finger-stick blood test, according to results of a pre-clinical study funded by Freedom Meditech, Inc.

14 Oct 2009

Diabetes care undergoes a paradigm shift to delay onset of full-blown disease

Diabetes care is undergoing a paradigm shift in which insulin is being prescribed earlier, for more conditions, in order to delay the onset of full-blown disease, according to a study released today by Scientia Advisors.

14 Oct 2009

Decreased expression of tumor suppressor gene PTEN transforms neurofibromas into cancer

Researchers at UCLA's Jonsson Comprehensive Cancer Center showed for the first time that the loss or decreased expression of the tumor suppressor gene PTEN plays a central role in the malignant transformation of benign nerve tumors called neurofibromas into a malignant and extremely deadly form of sarcoma.

14 Oct 2009

ADDF grant to support the evaluation of PPAR-sparing insulin sensitizers

Metabolic Solutions Development Company (MSDC) announced today that it has received a $100,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF) to support the evaluation of PPAR-sparing insulin sensitizers as a potential treatment for Alzheimer's disease.

14 Oct 2009

Luminous Medical to incorporate glucose sensor in its automated blood glucose monitor

Luminous Medical, Inc. announced today that it has reached agreement with a major supplier of electrochemical sensors for exclusive rights to incorporate its glucose sensor into Luminous' automated blood glucose monitor.

14 Oct 2009

Positive results from Metabolex' Phase 1 MBX-2982 clinical trial for treating type 2 diabetes

Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced positive results from two multiple ascending dose Phase 1 clinical trials of MBX-2982.

14 Oct 2009

Market Street's initiative to combat cold and flu season

As a complimentary service, Market Street pharmacies are expanding the grocer’s whole-health commitment to its guests by offering free antibiotics and prenatal vitamins to North Texans to help weather the cold and flu season through its “Free to Feel Better” program. Additionally, Market Street’s new partnership with Dallas-based MedicalEdge has transformed the Living Well ExpressCare Centers into more than just walk-in clinics.

14 Oct 2009

Glucose News and Research

VeriChip collaborates with DRI for further development of the glucose-sensing RFID microchip

Edwards Lifesciences announces third quarter 2009 results

New findings from ADVANCE clinical trial presented

InHealth awards Southern California, Northwestern and Stanford Universities $1.4M as research grants

Positive results from Isis Pharmaceuticals' ISIS 113715 Phase 2 study in type 2 diabetes patients

New results from ADVANCE provide important insights to reduce diabetes complications

Rexall Diabetes Starter Kit for newly diagnosed patients

Diabetes represents a global health threat

Children with history of diabetic ketoacidosis may have memory problems

Hygeia questions the recently issued state bid notification for breastpumps

MDEA program is accepting entries for its 2010 competition

Study shows type 2 diabetes patients treated with ACTOplus met experience blood sugar reduction

ValenTx to present its first clinical study for the treatment of morbid obesity

New non-invasive technology to measure glucose levels in the human eye

Diabetes care undergoes a paradigm shift to delay onset of full-blown disease

Decreased expression of tumor suppressor gene PTEN transforms neurofibromas into cancer

ADDF grant to support the evaluation of PPAR-sparing insulin sensitizers

Luminous Medical to incorporate glucose sensor in its automated blood glucose monitor

Positive results from Metabolex' Phase 1 MBX-2982 clinical trial for treating type 2 diabetes

Market Street's initiative to combat cold and flu season

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News